Literature DB >> 15306096

New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.

Daniel P Melby1, Joseph A Cytron, David G Benditt.   

Abstract

Neurally mediated reflex syncope (sometimes referred to as neurocardiogenic syncope), encompasses a group of disorders of which the best known and most frequently occurring forms are the vasovagal (or common) faint, and carotid sinus syndrome. Postmicturition syncope, defecation syncope, cough syncope, and other situational reflex faints are also included among these conditions. With the exception of carotid sinus syndrome in which cardiac pacing is effective, treatment of most neurally mediated reflex faints is shifting from reliance on various drugs to greater emphasis on education and nonpharmacologic therapy. Initial management should include counseling of patients regarding recognition of early warning symptoms, and avoidance of precipitating factors. Volume expansion with salt tablets or electrolyte-containing beverages and patient education on how to perform isometric arm contractions and/or leg crossing in order to abort impending syncope are also important. Thereafter, tilt-training has demonstrated benefit in several clinical studies. When symptoms remain despite the above-noted interventions, pharmacologic therapy with midodrine or a nonselective b-blocker can be considered. In the case of most neurally mediated reflex faints, permanent cardiac pacing should be reserved only for those older patients with significant bradycardia or asystole at time of syncope when all other interventions have failed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306096     DOI: 10.1007/s11886-004-0042-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  37 in total

1.  Guidelines on management (diagnosis and treatment) of syncope.

Authors:  M Brignole; P Alboni; D Benditt; L Bergfeldt; J J Blanc; P E Bloch Thomsen; J G van Dijk; A Fitzpatrick; S Hohnloser; J Janousek; W Kapoor; R A Kenny; P Kulakowski; A Moya; A Raviele; R Sutton; G Theodorakis; W Wieling
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

2.  Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing.

Authors:  C T Paul Krediet; Nynke van Dijk; Mark Linzer; Johannes J van Lieshout; Wouter Wieling
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

3.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.

Authors:  S J Connolly; R Sheldon; R S Roberts; M Gent
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

4.  Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope.

Authors:  Haruhiko Abe; Shoichi Kondo; Kiyotaka Kohshi; Yasuhide Nakashima
Journal:  Pacing Clin Electrophysiol       Date:  2002-10       Impact factor: 1.976

5.  Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope.

Authors:  Tony Reybrouck; Hein Heidbüchel; Frans Van De Werf; Hugo Ector
Journal:  Pacing Clin Electrophysiol       Date:  2002-10       Impact factor: 1.976

6.  Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.

Authors:  A Raviele; M Brignole; R Sutton; P Alboni; P Giani; C Menozzi; A Moya
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

7.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

8.  Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.

Authors:  M Biffi; G Boriani; P Sabbatani; G Bronzetti; L Frabetti; R Zannoli; A Branzi; B Magnani
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

9.  Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test.

Authors:  R Sheldon; S Rose; P Flanagan; M L Koshman; S Killam
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

10.  Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.

Authors:  Horacio Kaufmann; Daniela Saadia; Andrei Voustianiouk
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

View more
  2 in total

1.  The ACCF/AHA scientific statement on syncope: a document in need of thoughtful revision.

Authors:  D G Benditt
Journal:  Clin Auton Res       Date:  2006-09-29       Impact factor: 4.435

2.  Prolonged asystole provoked by head-up tilt testing.

Authors:  R Winker; M Frühwirth; P Saul; H W Rüdiger; T Pezawas; H Schmidinger; M Moser
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.